Prospective, Open-Label, Multicenter Study of Apremilast as Maintenance Therapy for Psoriasis Patients in Remission With Biologics
J Dermatol. 2025 Sep 19. doi: 10.1111/1346-8138.17968. Online ahead of print. ABSTRACT Although biologic agents have significantly improved therapeutic outcomes […]
